This article has Open Peer Review reports available.
Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101 - Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trastuzumab-mediated left ventricular remodeling among patients with HER2+ early breast cancer using cardiac MRI
© Pituskin et al; licensee BioMed Central Ltd. 2011
Received: 27 June 2011
Accepted: 27 July 2011
Published: 27 July 2011
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|27 Jun 2011||Submitted||Original manuscript|
|19 Jul 2011||Author responded||Author comments - Ian Paterson|
|Resubmission - Version 2|
|19 Jul 2011||Submitted||Manuscript version 2|
|24 Jul 2011||Author responded||Author comments - Ian Paterson|
|Resubmission - Version 3|
|24 Jul 2011||Submitted||Manuscript version 3|
|27 Jul 2011||Editorially accepted|
|27 Jul 2011||Article published||10.1186/1471-2407-11-318|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.